Abstract
ABSTRACTMultidrug-resistant (MDR) Gram-negative bacteria represent a notable public health threat, necessitating the urgent development of new antimicrobial agents. The β-barrel assembly machinery (BAM) complex, crucial for the biogenesis of outer membrane proteins in Gram-negative bacteria, emerges as a promising target for drug development. The BAM complex comprises five proteins (BamA–E), and its functionality might be disrupted by peptides targeting the BamA and BamB interface. We synthesized the peptide LTLR, located in the BamB interaction region with BamA inPseudomonas aeruginosa, and assessed its anti-P. aeruginosaactivity. This peptide demonstrated potential in enhancing antibiotic efficacy againstP. aeruginosa. Conversely, LRTL, a scrambled version of LTLR, lacked activity, underscoring the importance of specific target site binding for the peptide’s adjuvant effect. Subsequently, we tested the hypothesis that peptide dimerization enhances its effectiveness. A dimeric peptide, composed of two LTLR sequences, was tested and found to possess bactericidal activity againstP. aeruginosa, an outcome not observed with the monomeric form. Importantly, this dimeric peptide also showed bactericidal activity against MDRP. aeruginosastrains. In summary, our findings offer a foundation for developing novel antimicrobial agents against MDR Gram-negative bacteria.IMPORTANCEThis work demonstrates that (1) the β-barrel assembly machinery (BAM) complex-targeting peptides can exhibit antimicrobial activity and that (2) the dimeric forms of these peptides exhibit bactericidal activity against multidrug-resistant (MDR) strains ofP. aeruginosaandA. baumannii.
Publisher
Cold Spring Harbor Laboratory